Dr Christos Panotopoulos
Serendipity's core business is to create new innovative companies based on leading academic research.
Serendipity does this together with leading researchers, motivated entrepreneurs and by working closely with potential customers to ensure that the products and services developed meet the actual needs and requirements of the market. Our product development projects usually involve paying customers. This makes the value creation process more efficient while the product demand becomes more predictable.
Serendipity began operations in 2004 and has since established and operated more than ten companies; most of them research and development-intensive companies.
Serendipity Innovations
Medical Advisor
Ms Helena Peyron
BioMed Community is a life science cluster in north Denmark.
The community is a collaboration between 55 MedTech companies, Aalborg University, Aalborg Hospital, the City of Aalborg and the Aalborg Co-operation.
The main objective for BioMed Community is to foster innovation and generate growth by supporting our local entrepreneurs and enterprises engaged in health technology.
